Corpus Intelligence IC Memo — SALINAS VALLEY MEMORIAL HOSPITAL 2026-04-26 14:15 UTC
IC Memo — SALINAS VALLEY MEMORIAL HOSPITAL
Investment Committee Memorandum | CA | 240 beds | Grade B | EBITDA uplift $46.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SALINAS VALLEY MEMORIAL HOSPITAL

CCN 050334 | MONTEREY, CA | 240 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

SALINAS VALLEY MEMORIAL HOSPITAL is a 240-bed suburban community hospital in MONTEREY, CA with $636.0M in net patient revenue and a 9.1% operating margin. The hospital serves a payer mix of 38.9% Medicare, 3.3% Medicaid, and 57.8% commercial.

Thesis: Platform Growth. Our ML models identify $46.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 9.1% to 16.4% (+736bps).

Net Revenue HCRIS$636.0M
Current EBITDA COMPUTED$57.6M
Operating Margin COMPUTED9.1%
Occupancy HCRIS56.5%
Revenue / Bed COMPUTED$2.6M
Net-to-Gross HCRIS22.3%
Distress Probability ML44.4%

2. Market Context & Competitive Position

414
CA Hospitals
-4.9%
State Median Margin
194
Comparable Hospitals

CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of 9.1% places it above the state median. Among 194 size-comparable peers (120-480 beds), the median margin is -3.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (120-480), prioritizing same-state peers. 194 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SALINAS VALLEY MEMORIAL HOSPIT (Target)CA240$636.0M9.1%
RONALD REAGAN UCLACA446$2.62B-6.8%
LUCILE PACKARD CHILDRENS HOSPICA394$2.39B-0.8%
UCI MEDICAL CENTERCA397$1.90B-2.5%
CITY OF HOPE NATIONAL MEDICAL CA217$1.83B-10.7%
RADY CHILDRENS HOSPITAL - SAN CA401$1.82B14.8%
HARBOR-UCLA MEDICAL CENTERCA369$1.54B-6.4%
EL CAMINO HOSPITALCA388$1.34B11.7%
CHILDRENS HOSPITAL OF ORANGE CCA334$1.31B0.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $46.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$13.4M+210bp18mo
Cost to Collect4.5%2.5%$12.7M+200bp12mo
Denial Rate Reduction12.0%6.5%$12.6M+198bp12mo
A/R Days Reduction5200.0%3800.0%$7.7M+122bp9mo
Clean Claim Rate88.0%96.0%$407K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$13.4M
Cost to Collect
$12.7M
Denial Rate Reduction
$12.6M
A/R Days Reduction
$7.7M
Clean Claim Rate
$407K
Total EBITDA Uplift$46.8M
Current EBITDA$57.6M
+ RCM Uplift+$46.8M
Pro Forma EBITDA$104.4M
Current Margin9.1%
Pro Forma Margin16.4%
WC Released (1x)$24.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$88.6M$848.1M9.57x57.1%
Base (11x exit)10.0x11.0x$88.6M$961.7M10.85x61.1%
Bull Case9.0x11.0x$79.8M$1.14B14.35x70.4%
Bull (12x exit)9.0x12.0x$79.8M$1.27B15.96x74.0%
Bear Case11.0x10.0x$97.5M$585.3M6.00x43.1%
Bear (11x exit)11.0x11.0x$97.5M$675.5M6.93x47.3%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 194 hospitals with 120-480 beds
  • Same-state prioritization (n=195)
  • Comp margins: P25=-15.8% / P50=-3.9% / P75=4.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.